Subscribe to SPAC Research for full access.
March 4, 2024
News From the Past Week

Deal News

  • SK Growth Opportunities Corporation (SKGR) announced a deal to acquire Webull Corporation, a digital investment platform. The deal reflects an enterprise value of $7bn and is expected to close in 2H 2024.

  • Aetherium Acquisition Corp (GMFI) announced a deal to acquire Capital A International, a global brand management platform. The deal reflects an enterprise value of $1bn. No closing timeline was given.

  • Altitude Acquisition Corp. (ALTU) and Picard Medical agreed to terminate their business combination agreement, and ALTU announced a deal to acquire Vesicor Therapeutics, Inc., an early-stage biopharmaceutical company focused on the development of microvesicle-based therapeutics. The new deal includes $70mm in stock consideration. No closing timeline was given.

  • TG Venture Acquisition Corp. (TGVC) was notified that The Flexi Group has terminated its business combination agreement, citing the deal’s 5/5/2023 outside date.

  • Edify Acquisition Corp. (EAC) and Unique Logistics International agreed to terminate their business combination agreement.

Deal Closings & Approvals

  • Sizzle Acquisition Corp. (formerly SZZL) closed its acquisition of Critical Metals (European Lithium) on Tuesday 2/27/2024. Redemption statistics were not provided. Ordinary shares and warrants are now trading on the NASDAQ as “CRML” and “CRMLW.”.

  • Arisz Acquisition Corp. (formerly ARIZ) closed its acquisition of BitFuFu on Thursday 2/29/2024 with 1% of public shares remaining. Ordinary shares and warrants are now trading on the NASDAQ as “FUFU” and “FUFUW.”

  • Energem Corp. (ENCP) shareholders approved the company’s acquisition of Graphjet Technology at a meeting Wednesday 2/28/2024. Redemption statistics were not provided. The transaction is expected to close on Wednesday 3/6/2024 with ordinary shares and warrants trading on the NASDAQ as “GTI” and “GTIWW” thereafter.

  • Concord Acquisition Corp III (CNDB) shareholders approved the company’s acquisition of GCT Semiconductor at a meeting Tuesday 2/27/2024. Redemption statistics were not provided and no closing timeline was given.

IPOs
None.

New S-1's
None.

Liquidations
Name Ticker Size ($mm) Announced Liq. Date Trust Per Share
Revelstone Capital RCAC 165 2/28/2024 TBD TBD

Registrations Withdrawn
None.

Charter Extensions

  • MNTN extended its charter through 8/28/2024 with a monthly $0.03 per share sponsor contribution to trust. Approximately 43% of public shares remain, representing $83mm in trust.
  • ARYD extended its charter through 3/2/2025 with no sponsor contribution to trust. Approximately 22% of public shares remain, representing $37mm in trust.
  • COOL extended its charter through 6/30/2024 with no sponsor contribution to trust. Approximately less than 1% of public shares remain, representing $4mm in trust.

Upcoming Meetings and Deadlines

  • 3/4/2024 NSTD Liquidation deadline
  • 3/4/2024 NSTC Liquidation deadline
  • 3/4/2024 GODN Liquidation deadline (pending optional $0.033 deposit extension)
  • 3/5/2024 ADOC Australian Oilseeds Investments approval meeting
  • 3/5/2024 GMFI Charter extension meeting
  • 3/5/2024 DHCA Brand Engagement Network (“BEN”) approval meeting
  • 3/5/2024 HCMA Murano approval meeting
  • 3/6/2024 ESAC Sunergy approval meeting
  • 3/6/2024 ROSS Charter extension meeting (liquidation deadline 3/16/2024)
  • 3/6/2024 KWAC Wentworth Management Services approval meeting (liquidation deadline 3/15/2024)
  • 3/6/2024 CHAA Crown LNG Holdings approval meeting (liquidation deadline 5/17/2024)
  • 3/7/2024 IRAA Charter extension meeting
  • 3/8/2024 MCAA Charter extension meeting (liquidation deadline 3/9/2024)
  • 3/8/2024 TRON Charter extension meeting (liquidation deadline 3/21/2024)
  • 3/8/2024 BNIX Charter extension meeting (liquidation deadline 3/14/2024)
  • 3/8/2024 RWOD ANEW Medical approval meeting
  • 3/8/2024 XPDB Montana Technologies approval meeting
Disclosures: Site administrators may maintain positions in various SPAC securities and may trade in or out of those securities at any time without notice. Information from spacresearch.com is provided for informational purposes only and should not be relied upon as the basis for any investment decision. Nothing on spacresearch.com is a recommendation or solicitation to buy or sell any investment.
Copyright © 2024 SPAC Research, All rights reserved. SPAC Research is the source of all data unless otherwise noted.

Did we miss something important? Please contact us.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

February 12, 2024
News From the Past Week

Deal News

  • Slam Corp. (SLAM) announced a deal to acquire Lynk Global, Inc., a satellite telecom provider. The deal reflects a pre-money enterprise value of $800mm and is expected to close in 2H 2024.

  • Perception Capital Corp. III (PFTA) announced a deal to acquire RBio Energy, a newly-formed company based in Washington state with the intent to develop, acquire, and consolidate biorefinery, biogas, and biomass assets. The deal reflects an anticipated equity value of $350mm and is expected to close in Q2 2024.

Deal Closings & Approvals

  • Oxus Acquisition Corp. (formerly OXUS) closed its acquisition of Borealis Foods on Wednesday 2/7/2024 with less than 1% of public shares remaining. Ordinary shares and warrants are now trading on the NASDAQ as “BRLS” and “BRLSW.”

  • Aurora Technology Acquisition Corp. (formerly ATAK) closed its acquisition of DIH Holding on Wednesday 2/7/2024 with 2% of public shares remaining. Ordinary shares and warrants are now trading on the NASDAQ as “DHAI” and “DHAIW.”

IPOs
Name Ticker Raised ($mm) Sector Cash in Trust Coverage
Helix II HLXB 160 Healthcare 100.0% 0

New S-1's
Name Ticker Size ($mm) Underwriter Trust Funding Coverage
Black Hawk BKHA 60 EF Hutton 100.5% R/5

Liquidations
Name Ticker Size ($mm) Announced Liq. Date Trust Per Share
HH&L Acq. HHLA 414 2/7/2024 2/12/2024 $10.79
Frontier Investment. FICV 200 1/30/2024 TBD TBD

Registrations Withdrawn
Name Ticker Size ($mm) Underwriter Trust Funding Coverage
Arogo Capital. AOGO 104 EF Hutton 101.5% W

Charter Extensions

  • NFYS extended its charter through 6/8/2024 with a monthly $80,000 ($0.013 per share) sponsor contribution to trust. Approximately 18% of public shares remain, representing $67mm in trust.
  • ARIZ extended its charter through 11/22/2024 with a monthly $120,000 ($0.05 per share) sponsor contribution to trust. Approximately 34% of public shares remain, representing $26mm in trust.
  • JWSM extended its charter through 2/4/2025 with a monthly $25,000 ($0.018 per share) sponsor contribution to trust. Approximately 1% of public shares remain, representing $15mm in trust.
  • MAQC extended its charter through 8/7/2024 with a monthly $0.025 per share sponsor contribution to trust. Approximately 6% of public shares remain, representing $11mm in trust.
  • KRNL extended its charter through 8/5/2024 with no sponsor contribution to trust. Approximately 2% of public shares remain, representing $6mm in trust.
  • ARRW extended its charter through 8/6/2024 with no sponsor contribution to trust. Redemption statistics were not provided.
  • PUCK extended its charter through 8/10/2024 with no sponsor contribution to trust. Approximately 1% of public shares remain, representing $2mm in trust.
  • RMGC extended its charter through 8/9/2024 with no sponsor contribution to trust. Approximately 1% of public shares remain, representing $6mm in trust.
  • BLUA extended its charter through 5/2/2024 with a monthly $0.025 per share sponsor contribution to trust. Redemption statistics were not provided.

Upcoming Meetings and Deadlines

  • 2/12/2024 FLME Sable Offshore approval meeting
  • 2/12/2024 DPCS Liquidation deadline
  • 2/12/2024 LIBY Charter extension meeting
  • 2/12/2024 IRRX Charter extension meeting (liquidation deadline 2/15/2024)
  • 2/13/2024 AACI Charter extension meeting (liquidation deadline 2/17/2024)
  • 2/13/2024 WNNR Zapata AI approval meeting
  • 2/13/2024 RACY Charter extension meeting (liquidation deadline 2/15/2024)
  • 2/13/2024 PPYA Charter extension meeting (liquidation deadline 2/19/2024)
  • 2/13/2024 SLAC Charter extension meeting (liquidation deadline 2/17/2024)
  • 2/13/2024 BITE Charter extension meeting (liquidation deadline 2/17/2024)
  • 2/14/2024 CHAA Charter extension meeting (liquidation deadline 2/17/2024)
  • 2/14/2024 FTII Charter extension meeting (liquidation deadline 2/18/2024)
  • 2/15/2024 SZZL Critical Metals (European Lithium) approval meeting
  • 2/15/2024 ADRT Charter extension meeting (liquidation deadline 2/20/2024)
  • 2/15/2024 LBBB Nature's Miracle Inc. approval meeting
  • 2/15/2024 CBRG Liquidation deadline
  • 2/16/2024 ENCP Charter extension meeting (liquidation deadline 2/18/2024)
  • 2/16/2024 IFIN Charter extension meeting (liquidation deadline 2/23/2024)
  • 2/17/2024 CVII Liquidation deadline
Disclosures: Site administrators may maintain positions in various SPAC securities and may trade in or out of those securities at any time without notice. Information from spacresearch.com is provided for informational purposes only and should not be relied upon as the basis for any investment decision. Nothing on spacresearch.com is a recommendation or solicitation to buy or sell any investment.
Copyright © 2024 SPAC Research, All rights reserved. SPAC Research is the source of all data unless otherwise noted.

Did we miss something important? Please contact us.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

January 29, 2024

New Rules From the SEC
At long last, the SEC codified new rules for SPACs at a meeting last Wednesday, January 24. The new rules are ostensibly aimed at enhancing investor protection. But dissenting Commissioner Hester Peirce questioned whether the new rules are regulations in search of a problem. Is the commission too focused on using qualitative criteria to artificially chill a trend -- already mostly dormant -- of retail investors seeking exposure to early-stage companies that were using the SPAC format to access public markets?

The new rules contain limited adjustments to the SEC's original draft from March 2022. For in-depth color, you can check out this overview from law firm Vinson & Elkins and this Woodruff Sawyer interview with Doug Ellenoff.

As for the future of SPACs, market forces long ago took care of cooling 2021's boom fueled by loose monetary policy. And bulge-bracket firms have mostly stayed away from SPACs, representing just four of last year's 31 IPOs.

The regular-way IPO market is still tepid, and it would be a reach for SPACs to leapfrog broad sentiment for the traditional form of primary issuance. But last month's announcement by Screaming Eagle Acquisition Corp. (SCRM) to acquire Lionsgate Studios demonstrates that it's still possible for a high-quality sponsor to secure committed equity financing with minimal structure and bring a household name to market. Hopefully that deal serves as a blueprint for high-end sponsors to start coming back to the market en masse -- and to bring bulge bracket firms along with them.
News From the Past Week

Deal News

  • CSLM Acquisition Corp. (CSLM) announced a deal to acquire Fusemachines, a provider of enterprise AI products and solutions. The deal reflects an enterprise value of $200mm and includes a $19mm investment from affiliates of CSLM's sponsor. The transaction is expected to close in Q2 2024.

  • Global Systems Dynamics, Inc. (GSD) and DarkPulse agreed to terminate their business combination agreement.

  • Welsbach Technology Metals Acquisition Corp. (WTMA) signed an LOI with Evolution Metals, a trading company formed in January 2020 to counter the global critical mineral supply chain crisis.

Deal Closings & Approvals

  • Newcourt Acquisition Corp (formerly NCAC) closed its acquisition of Psyence Biomed Corp on Thursday 1/25/2024 with less than 1% of public shares remaining. Ordinary shares and warrants are now trading on the NASDAQ as “PBM” and “PBMWW.”

  • Deep Medicine Acquisition Corp. (DMAQ) shareholders approved the company’s acquisition of TruGolf at a meeting Friday 1/19/2024 with 2% of public shares remaining. No closing timeline was given.

IPOs
None.

New S-1's
None.

Liquidations
Name Ticker Size ($mm) Announced Liq. Date Trust Per Share
Magnum Opus OPA 200 1/22/2024 1/26/2024 $10.81
PepperLime Health PEPL 170 1/26/2024 2/8/2024 TBD
Northern Star II NSTB 400 1/25/2024 TBD $10.48

Registrations Withdrawn
None.

Charter Extensions

  • CLOE extended its charter through 1/17/2024 with a monthly $60,000 ($0.057 per share) sponsor contribution to trust. Approximately 8% of public shares remain, representing $12mm in trust.
  • APAC extended its charter through 7/20/2024 with a monthly $0.025 per share sponsor contribution to trust. SPAC Research has reached out for clarification on the number of shares remaining.
  • HCMA extended its charter through 4/25/2024 with a monthly $30,000 ($0.018 per share) sponsor contribution to trust. Approximately 6% of public shares remain, representing $18mm in trust.
  • EAC extended its charter through 7/20/2024 with a monthly $0.05 per share sponsor contribution to trust. Approximately 3% of public shares remain, representing $1mm in trust.
  • KYCH extended its charter through 7/27/2024 with a monthly $25,000 ($0.012 per share) sponsor contribution to trust. Approximately 18% of public shares remain, representing $22mm in trust.
  • EMLD extended its charter through 12/20/2024 with no sponsor contribution to trust. Approximately 19% of public shares remain, representing $51mm in trust.
  • NCAC extended its charter through 2/22/2024 with no sponsor contribution to trust. Less than 1% of public shares remain, representing $1mm in trust.

Upcoming Meetings and Deadlines

  • 1/29/2024 APTM Charter extension meeting
  • 1/29/2024 CSTA Charter extension meeting (liquidation deadline 1/29/2024)
  • 1/29/2024 ONYX Charter extension meeting (liquidation deadline 2/7/204)
  • 1/29/2024 DMAQ Liquidation deadline
  • 1/29/2024 LGST Tevogen Bio approval meeting
  • 1/30/2024 MBTC Cognos Therapeutics approval meeting
  • 1/30/2024 MARX Charter extension meeting (liquidation deadline 2/16/204)
  • 1/30/2024 NRAC Charter extension meeting (liquidation deadline 2/4/204)
  • 1/31/2024 ARRW iLearningEngines approval meeting (liquidation deadline 2/4/204)
  • 1/31/2024 CETU Charter extension meeting (liquidation deadline 2/2/204)
  • 2/1/2024 KRNL Charter extension meeting (liquidation deadline 2/5/204)
  • 2/2/2024 ARRW Charter extension meeting (liquidation deadline 2/4/204)
  • 2/2/2024 LCAA Lotus Technology approval meeting
  • 2/2/2024 CHEA Taiwan Color Optics approval meeting
  • 2/2/2024 NFYS Charter extension meeting (liquidation deadline 2/8/204)
  • 2/2/2024 OXUS Borealis Foods approval meeting
  • 2/2/2024 BLUA Charter extension meeting (liquidation deadline 2/2/204)
  • 2/4/2024 JWSM Liquidation deadline
  • 2/4/2024 GODN Liquidation deadline (pending optional $0.033 deposit extension)
Disclosures: Site administrators may maintain positions in various SPAC securities and may trade in or out of those securities at any time without notice. Information from spacresearch.com is provided for informational purposes only and should not be relied upon as the basis for any investment decision. Nothing on spacresearch.com is a recommendation or solicitation to buy or sell any investment.
Copyright © 2024 SPAC Research, All rights reserved. SPAC Research is the source of all data unless otherwise noted.

Did we miss something important? Please contact us.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

December 11, 2023

Q3 Trust Earnings


Quarterly reports from Q3 came out last month and we can now look back and calculate how much each SPAC earned during that time.
  • The data is a couple months old, but it's still useful for forecasting future trust account earnings.
Most SPACs remain invested in money-market funds containing a ladder of Treasurys with a maturity of 185 days or less.
  • You can see below that the 3-month Treasury yield averaged roughly 550 basis points during Q3 2023.
  • Short-term rates have been relatively stable around that level for months.
A trust account invested at a 5.5% interest rate would accrue at a rate of just under 1.4% per quarter.

Below we made a scatter plot of trust earnings during Q3 for SPACs whose share count remained static during the quarter. The results exclude the impact of any sponsor contributions to trust.
  • Many SPACs earned almost exactly 1.375% during Q3.
There's a meaningful concentration of data points around 1.375%, but many SPACs underperformed.
  • Smaller SPACs have an outsized chance of producing atypical trust earnings.
  • For a variety of reasons, it's more challenging to forecast trust estimates as the public float shrinks.
It's also worth noticing there isn't a huge difference between trusts that are "fully invested" vs. those that have communicated they are "in cash."
  • Trusts in cash experienced a very small underperformance.
  • As a result, we're adjusting our trust model again to bring the two types of estimates closer to parity.
News From the Past Week

Deal News

  • Zalatoris II Acquisition Corp (ZLS) announced a deal to acquire Ascotway, operating as Eco Modular, a sustainable modular building company. The deal reflects an enterprise value of $600mm and is expected to close in Q1 2024.

  • TMT Acquisition Corp (TMTC) announced a deal to acquire eLong Power Holding Limited, a provider of high power battery technologies for commercial and specialty vehicles and energy storage systems. The deal includes $450mm in stock consideration and is expected to close in 1H 2024.

  • Achari Ventures Holdings Corp. I (AVHI) announced a deal to acquire Vaso (OTCQX:VASO), a diversified medical technology company. The deal reflects an equity value of $176mm and is expected to close in Q1 2024.

  • RCF Acquisition Corp. (RCFA) announced a deal to acquire Blue Gold Holdings Limited, a newly formed company with the intent to acquire Tier-1 gold mining assets. The deal includes $115mm in stock consideration and is expected to close in Q2 2024.

Deal Closings & Approvals

  • 10X Capital Venture Acquisition Corp. II (formerly VCXA) closed its acquisition of African Agriculture on Wednesday 12/6/2023 with 1% of public shares remaining. Ordinary shares and warrants are now trading on the NASDAQ as “AAGR” and “AAGRW.”

  • Mobiv Acquisition Corp (formerly MOBV) closed its acquisition of Srivaru on Friday 12/8/2023 with 1% of public shares remaining. Ordinary shares and warrants are set to begin trading on the NASDAQ as “SVMH” and “SVHMW” Monday 11/11/2023.

  • PROOF Acquisition Corp I (formerly PACI) closed its acquisition of Volato on Monday 12/4/2023 with 6% of public shares remaining. Ordinary shares and warrants are now trading on the NYSE as “SOAR” and “SOAR/W.”

  • Dune Acquisition Corporation (DUNE) shareholders approved the company’s acquisition of Global Hydrogen Energy at a meeting Monday 12/4/2023. Redemption statistics were not provided and no closing timeline was given.

  • Clean Earth Acquisitions Corp. (CLIN) shareholders approved the company’s acquisition of Alternus Energy Group at a meeting Monday 12/4/2023 with less than 1% of public shares remaining. No closing timeline was given.

  • EF Hutton Acquisition Corporation I (EFHT) shareholders approved the company’s acquisition of E.C.D. Auto Design at a meeting Thursday 12/7/2023. Redemption statistics were not provided and no closing timeline was given.

Other Deal News & Rumors

  • Bloomberg reported that Rigel Resource Acquisition Corp. (RRAC) is in talks with South African gold miner Blyvooruitzicht Mining.

IPOs
Name Ticker Raised ($mm) Sector Cash in Trust Coverage
Aimei Health Technology AFJK 60 Healthcare 101.0% R

New S-1's
Name Ticker Size ($mm) Underwriter Trust Funding Coverage
Blue Room IBLU 200 Maxim 102.0% W+R
Legato Merger III LEGT 175 BTIG 100.0% W/2
FG Merger III Corp * 150 ThinkEquity 100.00% W/2
TechyBird Acq TKBD 60 Spartan 100.5% R


Liquidations
Name Ticker Size ($mm) Announced Liq. Date Trust Per Share
InterPrivate III Financial IPVF 259 12/6/2023 12/11/2023 $10.75
Thunder Bridge Capital III TBCP 414 12/8/2023 12/12/2023 $10.22
Khosla Ventures I KVSA 345 12/5/2023 12/12/2023 $10.75
Acropolis Infrastructure ACRO 345 12/4/2023 12/19/2023 $10.49
Black Mountain BMAC 276 12/6/2023 12/20/2023 TBD

Registrations Withdrawn
Name Ticker Size ($mm) Underwriter Trust Funding Coverage
CE Energy CEAC 100 Maxim 102.0% W
Aquarius II AQUB 60 EF Hutton 101.5% W+R

Charter Extensions

  • ROCL extended its charter through 12/3/2023 with a monthly $45,000 ($0.028 per share) sponsor contribution to trust. Approximately 14% of public shares remain, representing $17mm in trust.
  • GLLI extended its charter through 12/9/2024 with a monthly $60,000 ($0.023 per share) sponsor contribution to trust. Approximately 22% of public shares remain, representing $28mm in trust.
  • WINV extended its charter through 6/17/2024 with a monthly $55,000 ($0.048 per share) sponsor contribution to trust. Approximately 10% of public shares remain, representing $12mm in trust.
  • OXUS extended its charter through 6/8/2024 with a monthly $0.025 per share sponsor contribution to trust. Approximately 11% of public shares remain, representing $22mm in trust.
  • CNGL extended its charter through 12/2/2024 with a monthly $0.045 per share sponsor contribution to trust. Approximately 5% of public shares remain, representing $12mm in trust.
  • PGSS extended its charter through 4/30/2024 with a monthly $0.03 per share sponsor contribution to trust. Approximately 20% of public shares remain, representing $50mm in trust.
  • IVCB extended its charter through 6/17/2024 with a monthly $150,000 ($0.013 per share) sponsor contribution to trust. Approximately 33% of public shares remain, representing $127mm in trust.
  • DHCA extended its charter through 5/4/2024 with no sponsor contribution to trust. Approximately 7% of public shares remain, representing $22mm in trust.

Upcoming Meetings and Deadlines

  • 12/11/2023 WEL Charter extension meeting (liquidation deadline 12/13/2023)
  • 12/11/2023 ALTU Liquidation deadline
  • 12/11/2023 IXAQ Charter extension meeting
  • 12/11/2023 BRKH Charter extension meeting (liquidation deadline 12/15/2023)
  • 12/11/2023 VII Banzai approval meeting (liquidation deadline 12/28/2023)
  • 12/11/2023 LBBB Liquidation deadline
  • 12/12/2023 GAMC Charter extension meeting (liquidation deadline 12/19/2023)
  • 12/12/2023 NUBI Honeycomb Battery Company approval meeting (liquidation deadline 12/15/2023)
  • 12/12/2023 JAQC Filament Health approval meeting (liquidation deadline 12/17/2023)
  • 12/12/2023 KVSA Liquidation at ~$10.75 per share
  • 12/12/2023 BRD Liquidation at ~$10.74 per share
  • 12/12/2023 TBCP Liquidation at ~$10.22 per share
  • 12/13/2023 MBAC Liquidation at ~$10.60 per share
  • 12/13/2023 FRXB Liquidation at ~$10.45 per share
  • 12/13/2023 PRSR LeddarTech approval meeting (liquidation deadline 12/31/2023)
  • 12/13/2023 NETC Vast Solar approval meeting (liquidation deadline 12/18/2023)
  • 12/13/2023 BRLI Nukkleus approval meeting (liquidation deadline 12/23/2023)
  • 12/13/2023 DMYY Charter extension meeting
  • 12/14/2023 FXCO Liquidation deadline
  • 12/14/2023 KACL Charter extension meeting (liquidation deadline 12/16/2023)
  • 12/14/2023 LGST Charter extension meeting (liquidation deadline 12/15/2023)
  • 12/14/2023 CLAY Mobix Labs approval meeting
  • 12/14/2023 JAQC Charter extension meeting (liquidation deadline 12/17/2023)
  • 12/15/2023 TGAA Charter extension meeting
  • 12/15/2023 ACAB Charter extension meeting (liquidation deadline 12/19/2023)
  • 12/15/2023 USCT Charter amendment meeting
  • 12/15/2023 NUBI Charter extension meeting (liquidation deadline 12/15/2023)
  • 12/15/2023 BYTS Airship AI Holdings approval meeting
  • 12/17/2023 PRLH Liquidation deadline
Disclosures: Site administrators may maintain positions in various SPAC securities and may trade in or out of those securities at any time without notice. Information from spacresearch.com is provided for informational purposes only and should not be relied upon as the basis for any investment decision. Nothing on spacresearch.com is a recommendation or solicitation to buy or sell any investment.
Copyright © 2023 SPAC Research, All rights reserved. SPAC Research is the source of all data unless otherwise noted.

Did we miss something important? Please contact us.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.